Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Apyx Medical Inc (APYX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/28/2025: APYX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit 20.97% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 02/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 51.78M USD | Price to earnings Ratio - | 1Y Target Price 4 |
Price to earnings Ratio - | 1Y Target Price 4 | ||
Volume (30-day avg) 22401 | Beta 1.18 | 52 Weeks Range 0.93 - 1.99 | Updated Date 03/31/2025 |
52 Weeks Range 0.93 - 1.99 | Updated Date 03/31/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.66 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-19 | When Before Market | Estimate -0.16 | Actual -0.12 |
Profitability
Profit Margin -48.78% | Operating Margin (TTM) -21.43% |
Management Effectiveness
Return on Assets (TTM) -16.35% | Return on Equity (TTM) -114.21% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 56155051 | Price to Sales(TTM) 1.08 |
Enterprise Value 56155051 | Price to Sales(TTM) 1.08 | ||
Enterprise Value to Revenue 1.17 | Enterprise Value to EBITDA -5.33 | Shares Outstanding 37793900 | Shares Floating 29121701 |
Shares Outstanding 37793900 | Shares Floating 29121701 | ||
Percent Insiders 14.56 | Percent Institutions 45.84 |
Analyst Ratings
Rating 3.5 | Target Price 3 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold 3 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Apyx Medical Inc
Company Overview
History and Background
Apyx Medical Inc. (formerly Bovie Medical Corporation) was founded in 1921. It initially focused on electrosurgical instruments. Over time, it has evolved to specialize in energy-based medical devices, particularly its Renuvion technology.
Core Business Areas
- Surgical: Designs, develops, and markets advanced energy-based surgical products. Focuses on the Renuvion technology, which uses radiofrequency (RF) energy and helium plasma to contract tissue.
- Original Equipment Manufacturing (OEM): Manufactures electrosurgical generators and related products for other medical device companies. This includes private labeling and custom product development.
Leadership and Structure
Apyx Medical Inc. is led by its Chief Executive Officer. The company has a typical corporate structure with departments for research and development, sales and marketing, finance, and operations. Board of directors provides overall guidance.
Top Products and Market Share
Key Offerings
- Renuvion: Renuvion is a minimally invasive cosmetic technology that uses radiofrequency energy and helium plasma to contract tissue, particularly for skin tightening and aesthetic procedures. Market share data for this specific product is not readily available. Competitors include other energy-based aesthetic devices from companies like InMode (INMD) and Cynosure (CYNO).
- Electrosurgical Generators: Apyx Medical Inc. manufactures electrosurgical generators used in a variety of surgical procedures. Market share is difficult to pinpoint exactly due to the breadth of the electrosurgical market. Competitors include Medtronic (MDT) and Ethicon (JNJ).
Market Dynamics
Industry Overview
The medical device industry is characterized by technological innovation, stringent regulatory requirements, and strong competition. The aesthetic surgery segment is growing, driven by increasing demand for minimally invasive procedures.
Positioning
Apyx Medical Inc. is positioned as a player in the advanced energy-based surgical and aesthetic markets. Its Renuvion technology is seen as a differentiated offering for tissue contraction and skin tightening. Its competitive advantage lies in its unique technology and expanding application.
Total Addressable Market (TAM)
The global minimally invasive surgical instruments market is projected to reach approximately $45 billion by 2027. Apyx Medical Inc. targets a niche within this TAM with its Renuvion technology for specific applications. Market penetration is on-going
Upturn SWOT Analysis
Strengths
- Proprietary Renuvion technology
- Strong brand recognition in certain niche markets
- Experienced management team
- Focus on minimally invasive procedures
Weaknesses
- Limited financial resources compared to larger competitors
- Reliance on a single core technology
- Regulatory hurdles and clinical trial requirements
- Relatively small market capitalization
Opportunities
- Expanding applications for Renuvion technology
- Entering new geographic markets
- Potential for strategic partnerships or acquisitions
- Increasing demand for minimally invasive cosmetic procedures
Threats
- Competition from larger medical device companies
- Technological obsolescence
- Changing regulatory landscape
- Economic downturn impacting discretionary spending on cosmetic procedures
Competitors and Market Share
Key Competitors
- INMD
- CYNO
- MDT
- JNJ
Competitive Landscape
Apyx Medical Inc. faces intense competition from larger, more established medical device companies. Its competitive advantages lie in its Renuvion technology, but it needs to continue innovating and expanding its market presence to maintain its position.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by adoption of Renuvion technology. This is offset by any downturn in the market
Future Projections: Future growth will be driven by the expansion of the Renuvion technology into more procedures, new markets and better penetration.
Recent Initiatives: Recent initiatives include expanding sales and marketing efforts, conducting clinical trials to support new applications for Renuvion, and developing next generation products.
Summary
Apyx Medical Inc. is a company with an innovative technology, Renuvion, positioned in the growing aesthetic market. The company faces challenges from larger competitors and needs to strategically expand its market presence. Future success depends on continued innovation and market penetration. While Renuvion is a unique offering, Apyx needs to manage costs and grow revenue effectively. Regulatory hurdles also must be a consideration.
Similar Companies
- INMD
- CYNO
- MDT
- JNJ
Sources and Disclaimers
Data Sources:
- Company website, SEC filings, Market research reports, Analyst reports, Public press releases
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. The data provided is based on publicly available information and may not be entirely accurate or complete. Investment decisions should be made based on individual risk tolerance and thorough due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Apyx Medical Inc
Exchange NASDAQ | Headquaters Clearwater, FL, United States | ||
IPO Launch date 1987-01-01 | President, CEO & Director Mr. Charles D. Goodwin II | ||
Sector Healthcare | Industry Medical Devices | Full time employees 220 | Website https://apyxmedical.com |
Full time employees 220 | Website https://apyxmedical.com | ||
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.